Toggle navigation
Publicações
Investigadores
Instituições
0
Entrar
Autenticação Federada
(Clique na imagem)
Autenticação local
Recuperar Palavra-passe
Registar
Entrar
David Scott Miller
AuthID:
R-00K-250
Publicações
Confirmadas
Para Validar
Document Source:
All
Document Type:
Todos os Tipos de Documentos
Article (256)
Proceedings Paper (14)
Review (13)
Book Chapter (7)
Letter (4)
Note (4)
Editorial Material (3)
Unpublished (2)
Correction (1)
Year Start - End:
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
-
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
Order:
Ano Dsc
Ano Asc
Cit. WOS Dsc
IF WOS Dsc
Cit. Scopus Dsc
IF Scopus Dsc
Título Asc
Título Dsc
Results:
10
20
30
40
50
Publicações Confirmadas: 304
1
TÃTULO:
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Full Text
AUTORES:
Clements, A; Enserro, D; Strickland, KC; Previs, R; Matei, D; Mutch, D; Powell, M; Klopp, A;
David Scott Miller
; Small, W Jr; Disilvestro, P; Spirtos, N; Cosgrove, C; Sfakianos, G; Liu, JR; Vargas, R; Shahin, M; Corr, B; Dessources, K; Ueland, F;
Warshal, D;
Gillen, J;
Secord, AA;
...Mais
PUBLICAÇÃO:
2025
,
FONTE:
GYNECOLOGIC ONCOLOGY,
VOLUME:
193
INDEXADO EM:
Scopus
WOS
CrossRef
Unpaywall
NO MEU:
ORCID
2
TÃTULO:
Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma
AUTORES:
William Vintzileos; Hannah Beer;
David Scott Miller
; Jayanthi Lea;
PUBLICAÇÃO:
2025
,
FONTE:
Gynecologic Oncology Reports,
VOLUME:
58
INDEXADO EM:
CrossRef
Unpaywall
3
TÃTULO:
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
AUTORES:
Jalid Sehouli; Ignace Vergote; Erika Hamilton; Alejandro Pérez Fidalgo; Toon Van Gorp; Giovanni Scambia; Jaroslav Klat; Tally Levy; Stephen Welch; Debra L Richardson; Eva Maria Guerra Alía; Stéphanie Henry; Pauline Wimberger;
David Scott Miller
; Jerónimo Martínez; Bradley J Monk; Pratheek Kalyanapu; Monsoor Raza Mirza; Vicky Makker;
PUBLICAÇÃO:
2024
,
FONTE:
Oral Sessions
INDEXADO EM:
CrossRef
:
2
NO MEU:
ORCID
|
CIÊNCIAVITAE
4
TÃTULO:
Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC).
AUTORES:
Jung-Yun Lee; Baek-Yeol Ryoo; Jin Won Kim; Ann-Lii Cheng; Richard S Finn; Kosei Hasegawa; Vicky Makker; Masatoshi Kudo;
David Scott Miller
; Philippe Merle; Susanna Varkey Ulahannan; Tetsuya Hosaka; Takatoshi Sahara; Cixin S He; Karen O'Hara; Lea Dutta; Toshiyuki Tamai; Masafumi Ikeda;
PUBLICAÇÃO:
2024
,
FONTE:
Journal of Clinical Oncology,
VOLUME:
42,
NÚMERO:
16_suppl
INDEXADO EM:
CrossRef
NO MEU:
ORCID
|
CIÊNCIAVITAE
5
TÃTULO:
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
AUTORES:
Daniela E Matei; Danielle M Enserro; Marcus E Randall; David Mutch; William Small; Paul A DiSilvestro; Nick M Spirtos; David M O’Malley; Guilherme H Cantuaria; David Michelin; Steven Waggoner; Mark Shahin; Saketh Guntupalli; Olivia Lara; Frederick R Ueland; David Warshal; Albert Bonebrake; Krishnansu S Tewari; Annie Tan; Matthew A Powell;
Joan L Walker;
Alessandro D Santin;
Jong Hyeok Kim;
David Scott Miller
;
...Mais
PUBLICAÇÃO:
2024
,
FONTE:
Journal of Clinical Oncology
INDEXADO EM:
CrossRef
NO MEU:
ORCID
|
CIÊNCIAVITAE
6
TÃTULO:
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Full Text
AUTORES:
Vicky Makker; Jose Alejandro Perez Fidalgo; Giorgio Valabrega; Erika Hamilton; Toon Van Gorp; Jalid Sehouli; Klaudia Regináčová; Debra L Richardson; Tamar Perri; Amit M Oza;
David Scott Miller
; Eva Maria Guerra Alía; Ugo De Giorgi; Stephanie Henry; Daniel L Spitz; Pauline Wimberger; Markéta Bednaříková; Hye Sook Chon; Jerónimo Martínez Garcia; Carmela Pisano;
Jonathan S Berek;
Ignacio Romero;
Giovanni Scambia;
Lorena Fariñas Madrid;
Joseph Buscema;
Fabienne Schochter;
Kai Li;
Pratheek Kalyanapu;
Christopher J Walker;
Ignace Vergote;
...Mais
PUBLICAÇÃO:
2024
,
FONTE:
Gynecologic Oncology,
VOLUME:
185
INDEXADO EM:
Scopus
CrossRef
:
3
NO MEU:
ORCID
|
CIÊNCIAVITAE
7
TÃTULO:
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Featured Updates to the NCCN Guidelines
AUTORES:
Joyce Liu; Andrew Berchuck; Floor J Backes; Joshua Cohen; Rachel Grisham; Charles A Leath; Lainie Martin; Daniela Matei;
David Scott Miller
; Sharon Robertson; Lisa Barroilhet; Shitanshu Uppal; Andrea Wahner Hendrickson; David M Gershenson; Heidi J Gray; Ardeshir Hakam; Angela Jain; Gottfried E Konecny; John Moroney; Elena Ratner;
John Schorge;
Premal H Thaker;
Theresa L Werner;
Emese Zsiros;
Kian Behbakht;
Lee-May Chen;
Marie DeRosa;
Eric L Eisenhauer;
Gary Leiserowitz;
Babak Litkouhi;
Michael McHale;
Sanja Percac-Lima;
Kerry Rodabaugh;
Roberto Vargas;
Frankie Jones;
Emily Kovach;
Lisa Hang;
Swathi Ramakrishnan;
Ronald D Alvarez;
Deborah K Armstrong;
...Mais
PUBLICAÇÃO:
2024
,
FONTE:
Journal of the National Comprehensive Cancer Network,
VOLUME:
22,
NÚMERO:
8
INDEXADO EM:
CrossRef
NO MEU:
ORCID
|
CIÊNCIAVITAE
8
TÃTULO:
Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis.
AUTORES:
Vicky Makker; Debra L Richardson; Hye Sook Chon;
David Scott Miller
; Morten Mau-Sørensen; David Cibula; Flora Zagouri; Alejandro Pérez Fidalgo; Brian M Slomovitz; Robert L Coleman; Pratheek Kalyanapu; Rong Fan; Girish Gudi; Ignace Vergote;
PUBLICAÇÃO:
2024
,
FONTE:
Journal of Clinical Oncology,
VOLUME:
42,
NÚMERO:
16_suppl
INDEXADO EM:
CrossRef
NO MEU:
ORCID
|
CIÊNCIAVITAE
9
TÃTULO:
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
AUTORES:
Neil S Horowitz; Wei Deng; Ivy Peterson; Robert S Mannel; Spencer Thompson; Elizabeth Lokich; Tashanna Myers; Parvis Hanjani; David M O'Malley; Ki Young Chung;
David Scott Miller
; Frederick R Ueland; Don S Dizon; Austin Miller; Jyoti S Mayadev; Charles A Leath; Bradley J Monk;
PUBLICAÇÃO:
2024
,
FONTE:
Journal of Clinical Oncology,
VOLUME:
42,
NÚMERO:
16
INDEXADO EM:
Scopus
CrossRef
Unpaywall
NO MEU:
ORCID
10
TÃTULO:
Predicting Vte and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer
AUTORES:
Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven B Holloway; Ev Kakadiaris; Alexandra Spirtos;
David Scott Miller
; Jayanthi Lea;
PUBLICAÇÃO:
2024
INDEXADO EM:
CrossRef
NO MEU:
ORCID
|
CIÊNCIAVITAE
Adicionar à lista
Marked
Marcar Todas
Exportar
×
Publication Export Settings
BibTex
EndNote
APA
CSV
PDF
Export Preview
Print
×
Publication Print Settings
HTML
PDF
Print Preview
Página 1 de 31. Total de resultados: 304.
<<
<
1
2
3
4
5
6
7
8
9
>
>>
×
Selecione a Fonte
Esta publicação tem:
2 registos no
ISI
2 registos no
SCOPUS
2 registos no
DBLP
2 registos no
Unpaywall
2 registos no
Openlibrary
2 registos no
Handle
2 registos no
DataCite
Por favor selecione o registo que deve ser utilizado pelo Authenticus.
×
Comparar Publicações
© 2025 CRACS & Inesc TEC - All Rights Reserved
Política de Privacidade
|
Terms of Service
